Search studies using keywords
1,851 Studies in the database containing data with -log p ≥ 0 (showing 1521-1540)
Pages: << 71 72 73 74 75 76 77 78 79 80 >>
No data sets (in No Studies) added to Browser
Identifier Name Phenotype(s) Total p-values Related citationsAdd data sets to Browser Related data
HGVST207 plus GWAS of subclinical atherosclerosis in the Framingham Heart Study 
  • Abdominal aortic calcification
  • Common carotid artery intimal medial thickness
  • Internal carotid artery intimal medial thickness
  • Ankle brachial index
  • Coronary artery calcification
98
HGVST208 plus GWAS of kidney function and endocrine traits 
  • Cystatin C
  • Urinary albumin excretion
  • Thyroid stimulating hormone
  • Chronic kidney disease
  • Mean thyroid stimulating hormone
  • Glomerular filtration rate
84
HGVST209 plus GWAS and linkage analysis of hemostatic factors and hematological phenotypes in the Framingham Heart Study 
  • Hemoglobin
  • von Willebrand factor
  • Viscosity
  • Mean corpuscular hemoglobin
  • Mean corpuscular volume
  • Plasminogen activator inhibitor
  • Hematocrit
  • Tissue plasminogen activator
  • Collagen-induced platelet aggregation
  • Epi-induced platelet aggregation
  • Red blood cell count
  • Factor VII
  • Fibrinogen
  • ADP-induced platelet aggregation
72
HGVST210 plus GWAS of haemotological traits 
  • Hemoglobin
  • Mean corpuscular hemoglobin concentration
  • Mean corpuscular hemoglobin
  • Mean corpuscular volume
  • Fetal hemoglobin
  • Hemoglobin A2
  • Red blood cell count
  • Glycosylated hemoglobin
153
HGVST211 plus GWAS of nicotine dependence in two European populations 
  • Nicotine dependence, cigarettes per day
15
HGVST212 plus GWAS of pulmonary function phenotypes in the Framingham Heart Study 
  • Percent predicted forced expiratory flow
  • Percent predicted forced expiratory volume
  • Forced expiratory volume in one second slope
  • Mean forced expiratory volume in one second
  • Percent predicted forced vital capacity
  • Percent predicted forced expiratory flow/forced vital capacity ratio
  • Forced expiratory flow between 25th and 75th percentile slope
  • Mean forced vital capacity
  • Percent predicted forced expiratory volume/forced vital capacity ratio
  • Mean FEV1/FVC ratio
68
HGVST213 plus GWAS of electrocardiographic and heart rate variability traits in the Framingham Heart Study 
  • RR interval length
  • PR interval length
  • Heart rate variability: standard deviation of normal RR intervals
  • Heart rate variability: low frequency/high frequency power
  • QT interval length
  • Heart rate variability: total power
65
HGVST214 plus Meta-analysis of plasma lipid concentrations 
  • LDL cholesterol levels
  • Triglyceride levels
  • HDL cholesterol levels
118
HGVST215 plus GWAS of type II diabetes mellitus 
  • 0- to 120-min insulin sensitivity index
  • Fasting plasma glucose
  • Homeostasis model assessment of insulin resistance
  • 28-yr time-averaged fasting plasma glucose
  • Glycated hemoglobin
38
HGVST216 plus GWAS of plasma triglycerides 
  • HDL cholesterol
  • Triglycerides
22
HGVST217 plus GWAS of recombination rate 
  • Recombination rate, gender specific in males
3
HGVST218 plus GWAS of memory performance 
  • Number of words recalled after 5 minutes
2
HGVST219 plus GWAS of autism 
  • Autism
1
HGVST220 plus GWAS of serum uric acid levels Sardinia and Chianti cohorts 
  • Serum uric acid levels
45
HGVST221 plus GWAS of iris color 
  • Iris color
28
HGVST222 plus GWAS of type II diabetes mellitus and releated traits 
  • Mean fasting plasma glucose
  • 0- to 120-min insulin sensitivity index
  • Fasting plasma glucose
  • Homeostasis model assessment of insulin resistance
  • Glycated hemoglobin
  • Type II diabetes mellitus
742
HGVST223 plus GWAS of height 
  • Height
75
HGVST224 plus GWAS of bone mass and geometry in the Framingham Heart Study 
  • Hip geometry, shaft section modulus, gender differentiated in males
  • Hip geometry, shaft section modulus, gender differentiated in females
  • Hip geometry, shaft width, gender differentiated in females
  • Combined bone mineral density phenotypes, femoral neck bone mineral density, trochanater bone mineral density, lumbar spine bone mineral density, gender differentiated in males
  • Hip geometry, neck section modulus, gender differentiated in males
  • Combined bone mineral density phenotypes, femoral neck bone mineral density, trochanater bone mineral density, lumbar spine bone mineral density
  • Hip geometry, shaft section modulus
  • Hip geometery, neck shaft angle
  • Hip geometery, neck shaft angle, gender differentiated in females
  • Quantitative broadband ultrasound attentuation of the calcaneus
  • Bone mineral density and broadband ultrasound attenuation
  • Femoral neck bone mineral density
  • Trochanter bone mineral density, gender differentiated in males
  • Trochanter bone mineral density
  • Hip geometry, neck section modulus
  • Hip geometery, neck shaft angle, gender differentiated in males
  • Lumbar spine bone mineral density, gender differentiated in males
  • Hip geometry, femoral neck length, gender differentiated in females
  • Hip geometry, neck width, gender differentiated in females
  • Hip geometry, neck width
  • Femoral neck bone mineral density, gender differentiated in males
  • Femoral neck bone mineral density, gender differentiated in females
  • Combined bone mineral density phenotypes, femoral neck bone mineral density, trochanater bone mineral density, lumbar spine bone mineral density, gender differentiated in females
  • Hip geometery, shaft width, gender differentiated in males
  • Hip geometry, shaft width
  • Hip geometry, neck section modulus, gender differentiated in females
  • Trochanter bone mineral density, gender differentiated in females
99
HGVST225 plus GWAS of height in adults and children in a general population 
  • Height
5
HGVST226 plus GWAS of sleep and circadian phenotypes 
  • Usual bedtime
  • Epworth sleepiness scale score
  • Usual sleep duration
30